LIPUM.ST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 12:15):

Stats
Dzisiejszy wolumen	1 375.00
Średni wolumen	17 340.00
Kapitalizacja rynkowa	214.24M
EPS	SEK0 ( 2023-10-31 )
Następna data zysków	( SEK0 ) 2024-05-09
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.350
ATR14	SEK0.125 (2.17%)

Lipum AB (publ) Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lipum AB (publ) Finanse

Annual	2023
Przychody:	SEK0
Zysk brutto:	SEK0 (0.00 %)
EPS:	SEK-4.45

FY	2023
Przychody:	SEK0
Zysk brutto:	SEK0 (0.00 %)
EPS:	SEK-4.45

FY	2022
Przychody:	SEK0
Zysk brutto:	SEK-11 000.00 (0.00 %)
EPS:	SEK-6.02

FY	2021
Przychody:	SEK0.00
Zysk brutto:	SEK0.00 (0.00 %)
EPS:	SEK-12.54

Financial Reports:

No articles found.

Lipum AB (publ)

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116. The company was founded in 2010 and is headquartered in Umeå, Sweden.